Skip to main content

Compare Stocks

Date Range: 

 Burberry GroupBramblesCapitaLandCroda Internationalageas SA/NV
SymbolOTCMKTS:BURBYOTCMKTS:BXBLYOTCMKTS:CLLDYOTCMKTS:COIHDOTCMKTS:AGESY
Price Information
Current Price$30.01$16.56$5.52$47.82$64.20
52 Week RangeHoldN/ABuyN/AHold
MarketRank™
Overall Score0.81.31.01.21.3
Analysis Score0.00.00.00.00.0
Community Score1.62.02.52.42.1
Dividend Score0.02.50.82.52.5
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score2.51.91.91.31.9
Analyst Ratings
Consensus RecommendationHoldN/ABuyN/AHold
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap$12.02 billion$12.08 billion$11.08 billion$12.29 billion$12.49 billion
Beta1.310.991.10.530.89
Average Volume58,829132,3207,8682,0692,110
Sales & Book Value
Annual Revenue$3.37 billion$4.73 billion$4.57 billion$1.85 billion$16.91 billion
Price / Sales3.602.542.526.640.74
Cashflow$2.61 per share$1.43 per share$0.84 per shareN/A$10.79 per share
Price / Cash11.5011.576.58N/A5.95
Book Value$3.77 per share$3.46 per share$14.15 per shareN/A$76.11 per share
Price / Book7.964.790.390.84
Profitability
Net Income$154.73 million$448 million$1.57 billionN/A$1.10 billion
EPS$1.01$0.65N/A$1.29$5.69
Trailing P/E Ratio29.7125.488.7637.079.92
Forward P/E Ratio29.7120.7033.2011.51
P/E GrowthN/AN/AN/A2.26N/A
Net MarginsN/AN/AN/AN/A9.03%
Return on Equity (ROE)N/AN/AN/AN/A8.10%
Return on Assets (ROA)N/AN/AN/AN/A1.01%
Dividend
Annual PayoutN/A$0.36$0.12$0.58$2.19
Dividend YieldN/A2.17%2.17%1.21%3.41%
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/A55.38%N/A44.96%38.49%
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.23%0.64%0.69%N/A0.27%
Current Ratio1.95%1.12%0.79%N/A0.05%
Quick Ratio1.49%1.07%N/AN/AN/A
Ownership Information
Institutional Ownership Percentage0.17%0.16%N/A0.01%0.21%
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees10,16112,00010,4734,58010,044
Shares Outstanding404.87 million726.26 million2.09 billion257.02 million194.55 million
Next Earnings Date5/28/2021 (Estimated)N/AN/AN/A8/5/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
India and Pakistan cricketers approved entry for England tours despite countries being on Covid-19 red list with players and staff set to quarantine at the Ageas BowlIndia and Pakistan cricketers approved entry for England tours despite countries being on Covid-19 red list with players and staff set to quarantine at the Ageas Bowl
msn.com - May 17 at 9:26 AM
Ageas SA/ NV Stock Appears To Be Significantly OvervaluedAgeas SA/ NV Stock Appears To Be Significantly Overvalued
uk.finance.yahoo.com - May 15 at 8:14 AM
ageas SA/NV (OTCMKTS:AGESY) Hits New 1-Year High at $64.10ageas SA/NV (OTCMKTS:AGESY) Hits New 1-Year High at $64.10
americanbankingnews.com - May 14 at 6:28 PM
ageas SA/NVs (AGESY) "Buy" Rating Reiterated at Berenberg Bankageas SA/NV's (AGESY) "Buy" Rating Reiterated at Berenberg Bank
americanbankingnews.com - May 14 at 5:24 PM
ageas SA/NV (OTCMKTS:AGESY) Earns Overweight Rating from Morgan Stanleyageas SA/NV (OTCMKTS:AGESY) Earns Overweight Rating from Morgan Stanley
americanbankingnews.com - May 14 at 5:24 PM
Carson City Sheriffs Office receives recognition for 2020 Excellence in Law Enforcement Policy ManagementCarson City Sheriff's Office receives recognition for 2020 'Excellence in Law Enforcement Policy Management'
carsonnow.org - May 13 at 9:55 PM
Nevada vaccine website implants more trackers than any stateNevada vaccine website implants more trackers than any state
mysanantonio.com - May 13 at 9:55 PM
Ageas SA/ NV (AGESY) Q1 2021 Earnings Call TranscriptAgeas SA/ NV (AGESY) Q1 2021 Earnings Call Transcript
finance.yahoo.com - May 13 at 9:55 PM
Royal Bank of Canada Reiterates Sector Perform Rating for ageas SA/NV (OTCMKTS:AGESY)Royal Bank of Canada Reiterates Sector Perform Rating for ageas SA/NV (OTCMKTS:AGESY)
americanbankingnews.com - May 13 at 7:14 PM
Ageas reports good first quarter results 2021Ageas reports good first quarter results 2021
finance.yahoo.com - May 12 at 8:34 AM
ageas SA/NV (OTCMKTS:AGESY) Reaches New 12-Month High at $62.98ageas SA/NV (OTCMKTS:AGESY) Reaches New 12-Month High at $62.98
americanbankingnews.com - May 7 at 6:50 PM
ageas SA/NV (OTCMKTS:AGESY) Given Consensus Rating of "Hold" by Brokeragesageas SA/NV (OTCMKTS:AGESY) Given Consensus Rating of "Hold" by Brokerages
americanbankingnews.com - May 3 at 5:02 AM
ageas SA/NV (OTCMKTS:AGESY) Sees Large Drop in Short Interestageas SA/NV (OTCMKTS:AGESY) Sees Large Drop in Short Interest
americanbankingnews.com - May 3 at 2:54 AM
Ageas Federal Life earns Rs 1,959 cr premium in FY21Ageas Federal Life earns Rs 1,959 cr premium in FY21
daijiworld.com - April 29 at 1:09 PM
Ageas Federal Life FY21 profit dips 20% to Rs 119 crore, total premium up 6%Ageas Federal Life FY21 profit dips 20% to Rs 119 crore, total premium up 6%
moneycontrol.com - April 29 at 8:09 AM
ageas SA/NV (OTCMKTS:AGESY) Sets New 1-Year High at $62.12ageas SA/NV (OTCMKTS:AGESY) Sets New 1-Year High at $62.12
americanbankingnews.com - April 28 at 6:42 PM
ageas SA/NV (OTCMKTS:AGESY) Shares Cross Above Fifty Day Moving Average of $60.39ageas SA/NV (OTCMKTS:AGESY) Shares Cross Above Fifty Day Moving Average of $60.39
americanbankingnews.com - April 27 at 3:18 AM
Reigniting the Gauteng economy, part 2 of Makhura’s planReigniting the Gauteng economy, part 2 of Makhura’s plan
sundayworld.co.za - March 2 at 5:50 PM
Transaction Toolkit For A More Litigious M&A EnvironmentTransaction Toolkit For A More Litigious M&A Environment
law360.com - February 24 at 11:25 PM
Aviva exits from Turkey with £122m sale to AgeasAviva exits from Turkey with £122m sale to Ageas
intelligentinsurer.com - February 24 at 1:24 PM
Ageas reports 95.2% CORAgeas reports 95.2% COR
insuranceage.co.uk - February 24 at 8:23 AM
Ageas SA (AGESY) Upgraded to Buy: Heres WhyAgeas SA (AGESY) Upgraded to Buy: Here's Why
msn.com - February 22 at 5:08 PM
CRS-related coagulopathy in BCMA targeted CAR-T therapy: a retrospective analysis in a phase I/II clinical trialCRS-related coagulopathy in BCMA targeted CAR-T therapy: a retrospective analysis in a phase I/II clinical trial
nature.com - February 19 at 12:51 PM
Sort this out: Facebooks chaotic news ban in Australia blocks pages for fire services, charities and politicians'Sort this out': Facebook's chaotic news ban in Australia blocks pages for fire services, charities and politicians
elkodaily.com - February 18 at 7:53 AM
Debates over Beijings derelict Old Summer Palace are about more than historyDebates over Beijing's derelict Old Summer Palace are about more than history
msn.com - February 14 at 7:23 AM
DateCompanyBrokerageAction
5/14/2021Burberry GroupDeutsche Bank AktiengesellschaftReiterated Rating
5/14/2021Burberry GroupRoyal Bank of CanadaReiterated Rating
3/30/2021Burberry GroupUBS GroupReiterated Rating
3/15/2021Burberry GroupJPMorgan Chase & Co.Reiterated Rating
3/15/2021Burberry GroupSociete GeneraleReiterated Rating
2/4/2021Burberry GroupThe Goldman Sachs GroupUpgrade
2/2/2021Burberry GroupBerenberg BankInitiated Coverage
8/17/2020Burberry GroupJefferies Financial GroupUpgrade
7/16/2020Burberry GroupCredit Suisse GroupReiterated Rating
5/27/2020Burberry GroupCitigroupReiterated Rating
4/17/2020BramblesCLSAUpgrade
3/30/2020BramblesMorgan StanleyUpgrade
3/16/2021ageas SA/NVHSBCDowngrade
(Data available from 5/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.